136 related articles for article (PubMed ID: 28150306)
1. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
Mohan S; Pai SI; Bhattacharyya N
Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.
Zhang H; Dziegielewski PT; Biron VL; Szudek J; Al-Qahatani KH; O'Connell DA; Harris JR; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Apr; 42(1):30. PubMed ID: 23672952
[TBL] [Abstract][Full Text] [Related]
3. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
Lin CY; Chen WC; Wen YW; Fan KH; Lin JC; Ng SH; Tsai YT; Lee SR; Kang CJ; Lee LY; Chien CY; Hua CH; Wang CP; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Cancer Med; 2024 May; 13(10):e7127. PubMed ID: 38770540
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Radiotherapy and Survival in Oral Cavity Squamous Cell Carcinoma With Mandibulectomy.
Harley RJ; Iheagwara UK; Faraji F; Sridharan S; Kubik MW
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):233-239. PubMed ID: 38300601
[TBL] [Abstract][Full Text] [Related]
5. Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer.
Harris JP; Chen MM; Orosco RK; Sirjani D; Divi V; Hara W
JAMA Otolaryngol Head Neck Surg; 2018 Apr; 144(4):349-359. PubMed ID: 29522072
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and failure patterns after postoperative radiotherapy for oral cavity squamous cell carcinoma.
Tatsuno S; Doi H; Inada M; Uehara T; Wada Y; Ishikawa K; Tanaka K; Kitano M; Nishimura Y
Strahlenther Onkol; 2024 May; 200(5):389-399. PubMed ID: 37999789
[TBL] [Abstract][Full Text] [Related]
7. Impact of Adjuvant Radiotherapy in Squamous Cell Carcinoma of the Oral Cavity with Perineural Invasion.
Festa BM; Costantino A; Pace GM; Petruzzi G; Campo F; Pellini R; Spriano G; De Virgilio A
Laryngoscope; 2024 May; 134(5):2019-2027. PubMed ID: 37975480
[TBL] [Abstract][Full Text] [Related]
8. Population-based Long-term Outcomes for Squamous Cell Carcinoma of the Nasal Cavity.
Hamilton SN; Liu J; Holmes C; DeVries K; Olson R; Tran E; Berthelet E; Wu J; Chau N; Chan M; Thamboo A
Am J Clin Oncol; 2023 May; 46(5):199-205. PubMed ID: 36882926
[TBL] [Abstract][Full Text] [Related]
9. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
Laskar SG; Chaukar D; Deshpande M; Chatterjee A; Sinha S; Chakraborty S; Agarwal JP; Gupta T; Budrukkar A; Murthy V; Pai P; Chaturvedi P; Pantvaidya G; Deshmukh A; Nair D; Nair S; Prabhash K; Swain M; Kumar A; Noronha V; Patil V; Joshi A; DCruz A
Eur J Cancer; 2023 Mar; 181():179-187. PubMed ID: 36669426
[TBL] [Abstract][Full Text] [Related]
10. Atypical Squamous Verrucous Lesions of the Oral Cavity: Challenges in Interpretation of Small Incisional Biopsies.
Richards R; Agarwal S
Head Neck Pathol; 2023 Sep; 17(3):607-617. PubMed ID: 37204686
[TBL] [Abstract][Full Text] [Related]
11. Elective Neck Dissection for cT1-4 N0M0 Head and Neck Verrucous Carcinoma.
Patel AM; Vedula S; Haleem A; Choudhry HS; Tseng CC; Park RCW
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1187-1199. PubMed ID: 37278222
[TBL] [Abstract][Full Text] [Related]
12. A possible role of coarse fractionated radiotherapy in the management of gingival squamous cell carcinoma in dogs: A retrospective study of 21 cases from two referral centers in the UK.
Mosca A; Gibson D; Mason SL; Dobson J; Giuliano A
J Vet Med Sci; 2021 Apr; 83(3):447-455. PubMed ID: 33487622
[TBL] [Abstract][Full Text] [Related]
13. Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study.
Ju W; Zhang Y; Liu Y; Sun J; Li J; Dong M; Sun Q; Shi W; Zhao T; Zhou Z; Huang Y; Zhou X; Zhu D; Dou S; Zhang Z; He Y; Zhang C; Xia R; Zhu G; Zhong L
Int J Surg; 2023 Apr; 109(4):879-886. PubMed ID: 36999830
[TBL] [Abstract][Full Text] [Related]
14. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.
Chen HY; Zhao W; Na'ara S; Gleber-Netto FO; Xie T; Ali S; Thompson ZM; Buell J; Stafford H; Nagarajan P; Davies M; Wong MK; Migden MR; Sharma P; Myers JN; Gross ND; Amit M
JCO Precis Oncol; 2023 Jun; 7():e2200490. PubMed ID: 37285560
[TBL] [Abstract][Full Text] [Related]
15. Impact of postoperative radiation therapy for deeply invasive oral cavity cancer upstaged to stage III.
Cramer JD; Samant S; Heron DE; Ferris RL; Kim S
Head Neck; 2019 May; 41(5):1178-1183. PubMed ID: 30773733
[TBL] [Abstract][Full Text] [Related]
16. Changing Epidemiology of Oral Cavity Cancer in the United States.
Stepan KO; Mazul AL; Larson J; Shah P; Jackson RS; Pipkorn P; Kang SY; Puram SV
Otolaryngol Head Neck Surg; 2023 Apr; 168(4):761-768. PubMed ID: 35503657
[TBL] [Abstract][Full Text] [Related]
17. Oncological outcomes and prognostic factors of squamous cell carcinoma of the upper gingiva and hard palate: a retrospective study.
Cheval M; Lopez R; Delanoë F; Vergez S; Dupret-Bories A; Lusque A; Chabrillac E
Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4569-4576. PubMed ID: 37233750
[TBL] [Abstract][Full Text] [Related]
18. Protocol for Treatment of Oral Verrucous Carcinoma - A Systematic Review and Meta-Analysis.
Pal US; Maurya H; Yadav SK; Kumar V; Sowmya MV; Singh R
Ann Maxillofac Surg; 2023; 13(1):88-94. PubMed ID: 37711531
[TBL] [Abstract][Full Text] [Related]
19. Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma.
Amini A; Stokes WA; Jones BL; Sampath S; Kang RS; Gernon TJ; Maghami EG; Massarelli E; Bradley CJ; Karam SD
Head Neck; 2019 Jul; 41(7):2299-2308. PubMed ID: 30737961
[TBL] [Abstract][Full Text] [Related]
20. Guideline-compliant adjuvant chemotherapy for resected high risk oral cavity cancer: Homefield advantage.
Cherupalla B; Warren J; Kane A; Trendle M; Tassone P
Am J Otolaryngol; 2024; 45(1):104051. PubMed ID: 37738883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
